148 related articles for article (PubMed ID: 37304521)
1. P53 and survivin expression in renal cell carcinoma.
Radovanović M; Petrović M; Šantrić V; Milojević B; Zubelić A; Isaković A
Urol Ann; 2023; 15(2):186-190. PubMed ID: 37304521
[TBL] [Abstract][Full Text] [Related]
2. Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.
Baytekin F; Tuna B; Mungan U; Aslan G; Yorukoglu K
Urol Oncol; 2011; 29(5):502-7. PubMed ID: 19945306
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance.
Lei Y; Geng Z; Guo-Jun W; He W; Jian-Lin Y
Mol Cell Biochem; 2010 Nov; 344(1-2):23-31. PubMed ID: 20563741
[TBL] [Abstract][Full Text] [Related]
5. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
7. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
[TBL] [Abstract][Full Text] [Related]
8. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
9. Prognostic biomarkers in renal cell carcinoma: relevance of DNA ploidy in predicting disease-related survival.
Pinto AE; Monteiro P; Silva G; Ayres JV; Soares J
Int J Biol Markers; 2005; 20(4):249-56. PubMed ID: 16398407
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of p53 protein and tumor subtype and grade in renal cell carcinoma.
Mombini H; Givi M; Rashidi I
Urol J; 2006; 3(2):79-81. PubMed ID: 17590839
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
12. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
14. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
Parker AS; Kosari F; Lohse CM; Houston Thompson R; Kwon ED; Murphy L; Riehle DL; Blute ML; Leibovich BC; Vasmatzis G; Cheville JC
Cancer; 2006 Jul; 107(1):37-45. PubMed ID: 16736510
[TBL] [Abstract][Full Text] [Related]
15. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
Cohen C; Lohmann CM; Cotsonis G; Lawson D; Santoianni R
Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
[TBL] [Abstract][Full Text] [Related]
17. Significance of TNM staging, Demographic and Histologic Features in Predicting the Prognosis of Renal Cell Carcinoma.
Kucuk U; Pala EE; Sezer O; Cakir E; Bayol U; Divrik RT
Acta Chir Belg; 2015; 115(3):202-7. PubMed ID: 26158251
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis.
Ma C; Lu B; Sun E
Postgrad Med J; 2017 Apr; 93(1098):186-192. PubMed ID: 27489375
[TBL] [Abstract][Full Text] [Related]
19. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
20. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
